Silvercrest Asset Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.7M Sell
892,407
-184,357
-17% -$4.53M 0.11% 251
2025
Q4
$30.8M Sell
1,076,764
-204,287
-16% -$5.53M 0.21% 129
2025
Q3
$37.7M Buy
1,281,051
+230,414
+22% +$6.3M 0.25% 118
2025
Q2
$30.3M Buy
+1,050,637
New +$31.1M 0.2% 138
2024
Q3
Sell
-214,091
Closed -$7.11M 822
2024
Q2
$7.11M Sell
214,091
-2,258
-1% -$92.4K 0.05% 332
2024
Q1
$10.4M Buy
216,349
+29,721
+16% +$1.73M 0.07% 256
2023
Q4
$13.8M Sell
186,628
-19,943
-10% -$1.35M 0.1% 208
2023
Q3
$15.1M Buy
206,571
+5,314
+3% +$424K 0.11% 196
2023
Q2
$16.7M Buy
201,257
+34,088
+20% +$2.98M 0.12% 191
2023
Q1
$14.9M Sell
167,169
-2,077
-1% -$181K 0.11% 189
2022
Q4
$14.5M Buy
+169,246
New +$14.3M 0.11% 189
2021
Q2
Sell
-1,976
Closed -$253K 862
2021
Q1
$253K Buy
1,976
+668
+51% +$123K ﹤0.01% 771
2020
Q4
$235K Buy
+1,308
New +$291K ﹤0.01% 753

Other funds holding QDEL

Silvercrest Asset Management's QDEL Position: Q1 2026 in Review

Silvercrest Asset Management reduced its QuidelOrtho (QDEL) stake by 17% in Q1 2026, selling an estimated $4.53M and leaving 892,407 shares worth $14.7M. The position accounts for 0.11% of the portfolio, ranked #251.

Silvercrest Asset Management first reported a position in QDEL in Q4 2020 and has held it in 13 quarters since. The position peaked at $37.7M in Q3 2025. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Silvercrest Asset Management held 892,407 shares of QuidelOrtho worth $14.7M as of Q1 2026.
  • Silvercrest Asset Management sold 184,357 QuidelOrtho shares in Q1 2026, an estimated $4.53M.
  • QuidelOrtho made up 0.11% of Silvercrest Asset Management's portfolio in Q1 2026, its #251 holding.
  • Silvercrest Asset Management first reported a position in QuidelOrtho in Q4 2020 and has held it in 13 quarters since.
  • Silvercrest Asset Management's QuidelOrtho position peaked at $37.7M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.